Jayne Chacko NBC Connecticut #CTHealthNews #WeightLossDrugs #FDA #ObesityMedicine #PatientSafety To view or add a comment, sign in More Relevant Posts Rising specialty drug costs are driving employers to explore international drug importation programsbut these strategies raise serious legal, safety, and quality concerns
In fact, in one clinical trial , joint pain was actually less common among the people taking Ozempic than those taking a placebo
This helps reduce chronic inflammation and may benefit inflammatory skin conditions, including psoriasis and eczema
Balance Dietary Preferences and Intakes Many patients on Ozempic show impacts on food preferences and changes in eating habits
Yes, Im so excited to be here
The trial currently has almost 10,000 patients enrolled and is expected to assess a composite MACE endpoint consisting of cardiovascular (CV) death, non-fatal myocardial infarction, or non-fatal stroke in patients with T2D as is expected to readout in July 2024 (NCT03574597)